Kaseya Unveils Its Major Event Line-Up for 2023
With five large customer-centric conferences and multiple one-day locals and symposiums, Kaseya offers a can’t-miss…
4 years ago
Wire Stories
NICE Wins 2022 Best Practices Award for Technology Innovation Leadership in Asia-Pacific Market
Frost & Sullivan recognizes NICE for its industry-leading solutions that deliver efficient and smart AI-powered…
4 years ago
Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests
NIH RADx winner’s next gen Liberty16 Pro gets EUA AUCKLAND, New Zealand--(BUSINESS WIRE)--#COVIDCATCHER--Ubiquitome’s next generation…
4 years ago
Kyocera Plans New Manufacturing Plant in Japan’s Nagasaki Prefecture by 2026
Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity…
4 years ago
Dr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate…
4 years ago
Introducing THE BRIJ – A World of Arts and Culture
Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital…
4 years ago
Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney
MELBOURNE, Australia--(BUSINESS WIRE)--As rents continue to soar, Australian families are struggling more than ever before…
4 years ago
Dongying seeks trade opportunities in overseas markets
DONGYING, China--(BUSINESS WIRE)--Dongying, a city in East China’s Shandong province, has been helping local enterprises…
4 years ago
A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia
SAN FRANCISCO--(BUSINESS WIRE)--A third of global businesses predict the current inflationary environment to continue for…
4 years ago
ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer
Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a significant…
4 years ago